Thompson Davis & Co Has Trimmed Gentex (GNTX) Holding; Eagle Pharmaceuticals (EGRX) SI Increased By 1.43%

December 8, 2017 - By wolcottdaily

Eagle Pharmaceuticals Incorporated (NASDAQ:EGRX) had an increase of 1.43% in short interest. EGRX’s SI was 3.89M shares in December as released by FINRA. Its up 1.43% from 3.84M shares previously. With 353,000 avg volume, 11 days are for Eagle Pharmaceuticals Incorporated (NASDAQ:EGRX)’s short sellers to cover EGRX’s short positions. The SI to Eagle Pharmaceuticals Incorporated’s float is 42.14%. The stock decreased 1.07% or $0.62 during the last trading session, reaching $57.52. About 351,591 shares traded or 22.16% up from the average. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has risen 79.40% since December 8, 2016 and is uptrending. It has outperformed by 62.70% the S&P500.

Thompson Davis & Co decreased Gentex Corp (GNTX) stake by 94.53% reported in 2017Q2 SEC filing. Thompson Davis & Co sold 25,440 shares as Gentex Corp (GNTX)’s stock declined 8.68%. The Thompson Davis & Co holds 1,472 shares with $28,000 value, down from 26,912 last quarter. Gentex Corp now has $5.80 billion valuation. The stock increased 0.49% or $0.1 during the last trading session, reaching $20.43. About 1.48 million shares traded. Gentex Corporation (NASDAQ:GNTX) has risen 19.63% since December 8, 2016 and is uptrending. It has outperformed by 2.93% the S&P500.

Investors sentiment increased to 0.92 in 2017 Q2. Its up 0.07, from 0.85 in 2017Q1. It is positive, as 42 investors sold GNTX shares while 139 reduced holdings. 47 funds opened positions while 120 raised stakes. 226.47 million shares or 2.40% less from 232.03 million shares in 2017Q1 were reported. Retail Bank Of Nova Scotia reported 38,581 shares. Tradewinds Cap Limited Liability Corporation reported 853 shares stake. Capstone Asset Mgmt owns 27,680 shares. Mason Street Advsr Limited Liability accumulated 140,331 shares or 0.07% of the stock. Cape Cod Five Cents Bancorp owns 64,685 shares for 0.19% of their portfolio. Great Lakes Advsrs Ltd has 293,788 shares for 0.14% of their portfolio. Highvista Strategies Ltd Liability Corporation holds 0.11% or 24,400 shares. Castleark Management Lc invested in 0.07% or 105,300 shares. 7,360 were reported by Independent Portfolio Consultants. Kenmare Ltd Liability reported 4.08% stake. Hancock Holding, Mississippi-based fund reported 96,567 shares. Lsv Asset Mngmt owns 0% invested in Gentex Corporation (NASDAQ:GNTX) for 14,300 shares. Thompson Davis And holds 1,472 shares. Renaissance Techs Ltd Liability Corporation reported 0.01% stake. Schroder Inv Management Gp stated it has 0.22% of its portfolio in Gentex Corporation (NASDAQ:GNTX).

Among 6 analysts covering Gentex Corp (NASDAQ:GNTX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Gentex Corp has $2500 highest and $14 lowest target. $22’s average target is 7.68% above currents $20.43 stock price. Gentex Corp had 14 analyst reports since October 20, 2015 according to SRatingsIntel. Robert W. Baird upgraded Gentex Corporation (NASDAQ:GNTX) on Thursday, August 24 to “Outperform” rating. The rating was maintained by FBR Capital on Friday, October 21 with “Outperform”. KeyBanc Capital Markets maintained the shares of GNTX in report on Monday, November 13 with “Buy” rating. The rating was maintained by KeyBanc Capital Markets with “Buy” on Thursday, October 12. The stock of Gentex Corporation (NASDAQ:GNTX) has “Outperform” rating given on Monday, October 23 by Robert W. Baird. The firm has “Hold” rating given on Monday, July 24 by Craig Hallum. The firm has “Neutral” rating by Robert W. Baird given on Wednesday, January 27. The firm has “Neutral” rating given on Monday, December 19 by Susquehanna. FBR Capital maintained the stock with “Buy” rating in Wednesday, July 19 report. The stock of Gentex Corporation (NASDAQ:GNTX) earned “Buy” rating by Robert W. Baird on Friday, October 20.

Analysts await Gentex Corporation (NASDAQ:GNTX) to report earnings on January, 26. They expect $0.32 earnings per share, up 3.23% or $0.01 from last year’s $0.31 per share. GNTX’s profit will be $90.85M for 15.96 P/E if the $0.32 EPS becomes a reality. After $0.31 actual earnings per share reported by Gentex Corporation for the previous quarter, Wall Street now forecasts 3.23% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com